XML 53 R40.htm IDEA: XBRL DOCUMENT v3.25.0.1
Net Loss per Share (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Earnings Per Share [Abstract]    
Schedule of Securities Not Included in Diluted per Share Calculations

Securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in shares):

 

 

Three Months Ended
September 30,

 

 

For the Nine Months Ended
September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Options to purchase common stock

 

 

217,575

 

 

 

84,058

 

 

 

217,575

 

 

 

84,058

 

Warrants to purchase common stock

 

 

259,817

 

 

 

266,957

 

 

 

259,817

 

 

 

266,957

 

Preferred investment options

 

 

823,618

 

 

 

1,489,952

 

 

 

823,618

 

 

 

1,489,952

 

Total

 

 

1,301,010

 

 

 

1,840,967

 

 

 

1,301,010

 

 

 

1,840,967

 

Securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (in shares):

 

 

Year Ended December 31,

 

 

2023

 

 

2022

 

Options to purchase common stock

 

 

80,078

 

 

 

60,002

 

Warrants to purchase common stock

 

 

266,957

 

 

 

285,757

 

Preferred investment options

 

 

1,489,952

 

 

 

123,967

 

Total

 

 

1,836,987

 

 

 

469,726